摘要
Biotherapeutic treatments consisting of Therapeutic proteins (e.g. monoclonal antibodies produced in CHO cells), Vaccines and gene therapies (e.g. COVID-19 vaccines, adeno associated viral (AAV) vectors produced in HEK cells), Cell-based therapies (e.g. CAR T cells, Mesenchymal Stem Cells) are defining the advancements in healthcare system.
Animal cell culture is at the core of this biotherapeutic progress.
Optimized cellular nutrition is key to cultivate animal cells and efficiently produce biotherapeutics with consistently high quality.
Evonik cell culture solutions, dedicated to overcome the nutritional ingredients-related challenges which come on the way to higher cell culture performance
Increase performance in animal cell culture, with our portfolio of high-quality, chemically defined, specialty ingredients.
As a participant in this webinar you will learn about:
- Glutamine peptides: Limit detrimental by-products and improve cell-specific productivity thanks to a stabilized form of glutamine. Case study: Enhanced viral vector production using Glutamine peptides
- Cystine peptide: Enhance the cell viability and productivity by relying on a highly soluble form of cystine
- Tyrosine peptides: Solubilize up to 60 times more tyrosine in a feed at neutral pH than with the free amino acid
- Enhance your cell culture media formulation with our wide range of highly pure, non-animal-derived amino acids
- Carbohydrates: Tailor the energy supply and optimize the glycosylation profile of therapeutic proteins by using other carbohydrates than D-Glucose in cell culture
- PhytoChol® Biopharma: Supplement your cell culture medium with a plant-derived cholesterol
